Amgen Inc. Stock Performance
as on October 28, 2025 at 1:29 am IST
Day's Low
Day's High
$288.26$292
0.98%
Downside
0.30%
Upside
52 Week's Low
52 Week's High
$253.3$335.8812.99%
Downside
15.38%
Upside
Amgen Inc. share price movements today
- Previous Close
- $291.76
- Open
- $291.21
- Volume
- 873.5K
- Day's Low - High
- $288.26 - $292
- 52 Week Low - High
- $253.3 - $335.88
Amgen Inc. Historical Returns
- 1 Month Return
- + 6.88 %
- 3 Month Return
- -4.83 %
- 1 Year Return
- -7.96 %
- 3 Year Return
- + 9.18 %
- 5 Year Return
- + 30.56 %
Amgen Inc. Stock Fundamentals & Key Indicators
Check Amgen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$157.1B
EPS (TTM)
21.0448
Dividend Yield
2.63%
Quarterly Earnings Growth YOY
0.92%
PE Ratio (TTM)
23.88
Industry PE ratio
19.200384615384614
PEG Ratio
0.9577
EBITDA
16.1B
Revenue (TTM)
34.9B
Profit Margin
18.96%
Return On Equity TTM
99.14%
Amgen Inc. Stock Valuation
Track how Amgen Inc. P/E has moved over time to understand its valuation trends.
Amgen Inc. in the last 5 years
Lowest (12.34x)
December 31, 2021
Industry (19.20x)
October 27, 2025
Today (23.88x)
October 27, 2025
Highest (17.02x)
September 30, 2024
Today’s Price to Earnings Ratio: 23.88x
Amgen Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Amgen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $157.1B | 30.56% | 23.88 | 18.96% | |
| BUY | $740.0B | 525.82% | 54.06 | 25.91% | |
| BUY | $402.8B | 175.65% | 108.57 | 6.45% | |
| BUY | $458.7B | 33.01% | 18.38 | 27.26% | |
| BUY | $236.4B | 55.88% | 13.65 | 35.61% |
Stock Returns calculator for Amgen Inc. Stock including INR - Dollar returns
The Amgen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Amgen Inc. investment value today
Current value as on today
₹96,916
Returns
Returns from Amgen Inc. Stock
Dollar Returns*
₹5,074 (+5.07%)
Analyst Recommendation on Amgen Inc. Stock
Based on 37 analysts
56.76%
Buy
35.14%
Hold
8.11%
Sell
Based on 37 analysts, 56.76% of analysts recommend a 'BUY' rating for Amgen Inc.. Average target price of $311.65
Amgen Inc. Share Price Target
Get share price movements and forecasts by analysts on Amgen Inc..
What analysts predicted
6.59%UPSIDE
Target Price
$311.65
Current Price
$291.12
Analyzed by
37 Analysts
Target
$311.65
Amgen Inc. target price $311.65, a slight upside of 6.59% compared to current price of $291.12. According to 37 analysts rating.
Amgen Inc. Stock’s Investor Sentiment and Interest
Search interest for Amgen Inc. Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:58% versus previous 30 day period
Amgen Inc. Quarterly Profit & Loss
All numbers in Millions USD
Amgen Inc. Annual Profit & Loss
All numbers in Millions USD
Amgen Inc. Quarterly Cash Flow
All numbers in Millions USD
Amgen Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Amgen Inc. Stock
Check out the Mutual Funds with significant holdings in Amgen Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.26516% | 4270 |
 ICICI Prudential US Bluechip Equity Fund Direct Plan Growth | 1.79833% | 24000 |
ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.81428% | 8267 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 1.29492% | 841 |
Global Institutional Holdings in Amgen Inc.
Amgen Inc. News & Key Events
Today's Timeline - 27 October
Tue, 03:32 AM
-Amgen updates on Phase 1b study for tarlatamab and AB248 in extensive stage small cell lung cancer.
Tue, 03:32 AM
-Amgen's Phase 3 study on Etelcalcetide for pediatric CKD patients shows potential for market expansion.
Tue, 03:37 AM
-Amgen conducts observational study on Repatha® effectiveness in reducing cardiovascular events in ASCVD patients.
Today's Timeline - 27 October
Tue, 03:43 AM
-Amgen's Phase 2 study on blinatumomab for pediatric leukemia shows promise for investor confidence.
Tue, 03:44 AM
-Amgen's Phase 3 study on maridebart cafraglutide aims to improve cardiovascular outcomes in patients with ASCVD.
Insights on Amgen Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Amgen Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $8.14 billion to $9.16 billion, which represents an average increase of 11.1% per quarter.
NO EFFECTAgainst Peers
In the last 3 years, Eli Lilly And Company has given 48.5% return, outperforming this stock by 39.3%
- NO EFFECT
Against Peers
In the last 1 year, Abbvie Inc has given 21.4% return, outperforming this stock by 29.4%
NEGATIVE IMPACTProfit Down
Amgen Inc. has experienced a decline in its net profit over the last two quarters. Specifically, the net profit decreased from $1.73 billion to $1.43 billion. This represents an average decrease of 17.2% per quarter.
- NEGATIVE IMPACT
Price Dip
In the last 7 days, AMGN stock has moved down by -3.8%
About Amgen Inc.
| Organisation | Amgen Inc. |
| Headquarters | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 |
| Industry | Health Technology |
| CEO | Mr. Robert A. Bradway |
| E-voting on shares | Click here to vote |
Key Management of Amgen Inc.
Name | Title |
|---|---|
Mr. Peter H. Griffith | Executive VP & CFO |
Dr. David M. Reese M.D. | Executive VP & CTO |
Mr. Murdo Gordon | Executive Vice President of Global Commercial Operations |
Dr. James E. Bradner M.D. | Executive Vice President of Research & Development |
Mr. Robert A. Bradway | Chairman, CEO & President |
Mr. Esteban Santos | Executive Vice President of Operations |
Mr. Matthew C. Busch | Chief Accounting Officer & VP of Finance |
Mr. Scott Skellenger | Senior VP & Chief Information Officer |
Mr. Howard Y. Chang M.D., Ph.D. | Senior VP of Global Research & Chief Scientific Officer |
Mr. Jonathan P. Graham J.D. | Executive VP, General Counsel & Secretary |
FAQs
What is Amgen Inc. share price today?
Amgen Inc. share price today is $291.12 as on at the close of the market. Amgen Inc. share today touched a day high of $292 and a low of $288.26.
What is the 52 week high and 52 week low for Amgen Inc. share?
Amgen Inc. share touched a 52 week high of $335.88 on and a 52 week low of $253.3 on . Amgen Inc. stock price today i.e. is closed at $291.12,which is 13.33% down from its 52 week high and 14.93% up from its 52 week low.
What is Amgen Inc.'s market capitalisation today?
Amgen Inc. market capitalisation is $0.16T as on .
How to invest in Amgen Inc. Stock (AMGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Amgen Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amgen Inc. Shares that will get you 0.0052 shares as per Amgen Inc. share price of $291.12 per share as on October 28, 2025 at 1:29 am IST.
What is the minimum amount required to buy Amgen Inc. Stock (AMGN) from India?
Indian investors can start investing in Amgen Inc. (AMGN) shares with as little as ₹88.189 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.89 in Amgen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Amgen Inc. share’s latest price of $291.12 as on October 28, 2025 at 1:29 am IST, you will get 0.0344 shares of Amgen Inc.. Learn more about
fractional shares .
What are the returns that Amgen Inc. has given to Indian investors in the last 5 years?
Amgen Inc. stock has given 30.56% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?